HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisao Imai Selected Research

Heavy Chain Fusion Regulatory Protein 1

9/2010Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.
12/2009CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
10/2009Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
2/2009Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisao Imai Research Topics

Disease

72Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 02/2005
63Neoplasms (Cancer)
05/2022 - 02/2007
17Lung Neoplasms (Lung Cancer)
12/2021 - 02/2007
12Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 07/2010
11Disease Progression
01/2022 - 08/2014
9Neoplasm Metastasis (Metastasis)
11/2020 - 02/2009
8Thymoma (Thymic Carcinoma)
01/2022 - 06/2009
7Neutropenia
12/2021 - 04/2007
6Opioid-Induced Constipation
05/2022 - 01/2020
5Nausea
03/2022 - 01/2019
5Interstitial Lung Diseases (Interstitial Lung Disease)
08/2021 - 01/2015
4Carcinoma (Carcinomatosis)
01/2022 - 01/2019
4Fever (Fevers)
12/2021 - 02/2007
4Adenocarcinoma
12/2020 - 10/2009
4Pneumonia (Pneumonitis)
01/2020 - 01/2015
3Vomiting
03/2022 - 01/2021
3Pericardial Effusion
12/2021 - 02/2005
3Constipation
09/2021 - 01/2021
3Diarrhea
08/2021 - 10/2015
3Liver Diseases (Liver Disease)
08/2021 - 10/2015
3Exanthema (Rash)
08/2021 - 10/2015
3Inflammation (Inflammations)
01/2020 - 02/2007
3Thrombocytopenia (Thrombopenia)
03/2014 - 04/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 02/2009
2Body Weight (Weight, Body)
10/2021 - 01/2017
2Cancer Pain
09/2021 - 01/2020
2Head and Neck Neoplasms (Head and Neck Cancer)
08/2021 - 12/2008
2Thymus Neoplasms (Thymus Neoplasm)
01/2021 - 01/2014
2Breast Neoplasms (Breast Cancer)
01/2021 - 01/2019
2Anorexia
12/2018 - 06/2015
2Lymphatic Metastasis
03/2016 - 09/2010
1Disorders of Excessive Somnolence (Hypersomnia)
03/2022
1Neuroendocrine Carcinoma
01/2022
1Pain (Aches)
12/2021

Drug/Important Bio-Agent (IBA)

17ErbB Receptors (EGF Receptor)IBA
09/2021 - 08/2013
16Carboplatin (JM8)FDA LinkGeneric
10/2022 - 02/2007
15Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2019 - 11/2007
13Tyrosine Kinase InhibitorsIBA
09/2021 - 08/2013
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2010 - 12/2008
7Opioid Analgesics (Opioids)IBA
01/2022 - 01/2019
7Pharmaceutical PreparationsIBA
09/2021 - 02/2007
6amrubicinIBA
10/2022 - 07/2010
6PlatinumIBA
01/2022 - 01/2013
6Gefitinib (Iressa)FDA Link
11/2021 - 02/2007
6Docetaxel (Taxotere)FDA Link
12/2020 - 02/2007
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
5pembrolizumabIBA
11/2021 - 02/2020
5Cisplatin (Platino)FDA LinkGeneric
05/2019 - 02/2012
5GemcitabineFDA Link
07/2017 - 10/2007
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2016
4osimertinibIBA
12/2020 - 01/2019
4Heavy Chain Fusion Regulatory Protein 1IBA
09/2010 - 02/2009
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2022 - 04/2009
3Etoposide (VP 16)FDA LinkGeneric
10/2022 - 01/2016
3naldemedineIBA
05/2022 - 11/2021
3Olanzapine (Zyprexa)FDA Link
03/2022 - 01/2021
3NivolumabIBA
01/2022 - 12/2020
3Immune Checkpoint InhibitorsIBA
11/2021 - 01/2020
3AntibodiesIBA
08/2021 - 03/2021
3Deoxyglucose (2 Deoxy D glucose)IBA
02/2020 - 11/2007
3Paclitaxel (Taxol)FDA LinkGeneric
10/2018 - 01/2012
3Vinorelbine (Navelbine)FDA LinkGeneric
01/2013 - 02/2007
2atezolizumabIBA
10/2022 - 06/2022
2AntiemeticsIBA
03/2022 - 07/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
03/2022 - 01/2021
2Neurokinin-1 Receptor AntagonistsIBA
03/2022 - 01/2021
2C-Reactive ProteinIBA
10/2021 - 01/2020
2AlbuminsIBA
10/2021 - 01/2020
2LigandsIBA
01/2021 - 01/2020
2B7-H1 AntigenIBA
12/2020 - 02/2020
2Bevacizumab (Avastin)FDA Link
03/2020 - 05/2019
2Albumin-Bound PaclitaxelFDA Link
01/2020 - 01/2017
2S-1 plus cisplatinIBA
05/2019 - 02/2012
2Pemetrexed (MTA)FDA Link
05/2019 - 03/2014
2AfatinibIBA
12/2018 - 01/2017
2Proteins (Proteins, Gene)FDA Link
10/2017 - 10/2016
2Endoplasmic Reticulum Chaperone BiPIBA
10/2017 - 10/2016
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2017 - 10/2016
2Carrier Proteins (Binding Protein)IBA
10/2017 - 10/2016
2Transaminases (Aminotransferases)IBA
05/2010 - 04/2007
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
03/2022
1Carcinoembryonic AntigenIBA
01/2022
1Keratin-19 (Keratin 19)IBA
01/2022
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022
1big gastrinIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1squamous cell carcinoma-related antigenIBA
01/2022
1Phosphopyruvate Hydratase (Enolase)IBA
01/2022
1Dihydrotachysterol (AT 10)IBA
01/2022

Therapy/Procedure

31Drug Therapy (Chemotherapy)
03/2022 - 02/2007
27Therapeutics
09/2021 - 02/2007
7Chemoradiotherapy
01/2022 - 01/2014
7Radiotherapy
11/2020 - 01/2013
3Combination Drug Therapy (Combination Chemotherapy)
06/2022 - 01/2013
3Adjuvant Chemotherapy
01/2022 - 01/2013
3Catheters
12/2021 - 02/2005
2Aftercare (After-Treatment)
08/2021 - 06/2020
2Activities of Daily Living (ADL)
10/2019 - 11/2017
2Thoracotomy
11/2013 - 12/2008